(Q54646751)

2 June 2018

title

Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations. (English)

1 reference

2 June 2018

author name string

M J Postma

1

1 reference

2 June 2018

J M Bos

2

1 reference

2 June 2018

R Welte

3

1 reference

2 June 2018

R de Groot

4

1 reference

2 June 2018

W Luytjes

5

1 reference

2 June 2018

H C Rümke

6

1 reference

2 June 2018

P Beutels

7

1 reference

2 June 2018

publication date

1 February 2004

1 reference

2 June 2018

The European Journal of Health Economics

published in

1 reference

2 June 2018

volume

5

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

54-57

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1007/s10198-003-0201-6

exact match

0 references

cites work

Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women

1 reference

12 December 2020

The cost-effectiveness of routine childhood varicella vaccination in Germany

1 reference

12 December 2020

Cost-effectiveness of routine antenatal varicella screening.

1 reference

12 December 2020

The burden of varicella in Germany. Potential risks and economic impact.

1 reference

12 December 2020

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

1 reference

12 December 2020

Costs And Benefits Of Routine Varicella Vaccination In German Children

1 reference

12 December 2020

Antiviral therapies for herpes zoster infections. Are they economically justifiable?

1 reference

12 December 2020

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

1 reference

12 December 2020

Prevention of chickenpox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles

1 reference

12 December 2020

Health economic guidelines--similarities, differences and some implications

1 reference

12 December 2020

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

1 reference

12 December 2020

The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).

1 reference

12 December 2020

Economic evaluations of varicella vaccination programmes: a review of the literature

1 reference

12 December 2020

A practical guide for calculating indirect costs of disease

1 reference

12 December 2020

Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection

1 reference

12 December 2020

The cost-effectiveness of varicella vaccination in Canada

1 reference

12 December 2020

Varicella vaccine and shingles

1 reference

12 December 2020

Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.

1 reference

12 December 2020

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

1 reference

12 December 2020

Modelling the impact of immunization on the epidemiology of varicella zoster virus

1 reference

12 December 2020

10.1007/S10198-003-0201-6

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018